Volume 5, Number 2—April 1999
Dispatch
Evaluating Diagnosis and Treatment of Oral and Esophageal Candidiasis in Ugandan AIDS Patients
Table
Characteristics of patients participat- ing in the study
| No. | Mean age (yr) (S.D.) | Sex M/F | |
|---|---|---|---|
| Oral candidiasis | 85 | 24.0 (6.7) | 32 / 53 |
| Esophageal symptomsa | 40 | 17 / 23 | |
| Nystatin group | 20 | 23.9 (6.1) | 7 / 13 |
| Miconazole group | 20 | 23.7 (6.6) | 8 / 12 |
| Esophageal candidiasis | 77 | 23.7 (6.4) | 27 / 50 |
| Nystatin group | 37 | 24.2 (6.5) | 12 / 22 |
| Miconazole group | 40 | 23.4 (6.1) | 15 / 28 |
aEsophageal symptoms are any of the following: odinophagia, dysphagia, retrosternal burning pain.
Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.